Introduction {#section1-2333794X17743424}
============

Pelvic incontinence (PI) (urinary and/or fecal) refers to involuntary or uncontrollable leakage of urine and/or feces. Development of urinary incontinence (UI) in children is usually attributed to 3 etiologies: anatomic lesions, neurologic lesions, or behavioral issues.^[@bibr1-2333794X17743424]^ However, in patients with cystic fibrosis (CF), repeated coughing reduces strength of pelvic floor muscle that causes them to lose control resulting in incontinence.^[@bibr2-2333794X17743424]^

Urinary incontinence in CF patients can have a negative impact on their overall health and general well-being. Studies have reported leakage affecting their ability to perform spirometry and airway clearance.^[@bibr3-2333794X17743424][@bibr4-2333794X17743424]-[@bibr5-2333794X17743424]^ Patients with symptoms are unaware of treatment options.^[@bibr5-2333794X17743424]^ Once leakage occurs, there is progressive decline in pelvic muscular function causing worsening symptoms.^[@bibr6-2333794X17743424]^

The prevalence of UI in women with CF has been reported in several studies and clearly documented (30% to 68%),^[@bibr2-2333794X17743424],[@bibr5-2333794X17743424],[@bibr7-2333794X17743424],[@bibr8-2333794X17743424]^ whereas the prevalence in men (2.4% to 16%) is more controversial.^[@bibr9-2333794X17743424],[@bibr10-2333794X17743424]^ There are few studies that evaluated incontinence in children with CF, mostly reported in small numbers of patients (65 patients,^[@bibr3-2333794X17743424]^ 81 patients,^[@bibr11-2333794X17743424]^ 54 patients,^[@bibr12-2333794X17743424]^ 128 patients,^[@bibr13-2333794X17743424]^ and 12 patients^[@bibr14-2333794X17743424]^). The prevalence of incontinence is reportedly higher in girls with CF (31%) when compared with asthmatic and healthy girls (16% and 7%, respectively).^[@bibr15-2333794X17743424]^ However, the prevalence of fecal incontinence (FI) is less well described. One study reported the prevalence of FI in children with CF as 8.6%.^[@bibr13-2333794X17743424]^

Our study aim is to identify prevalence of PI in patients with CF followed at our center. The correlation between incontinence and severity of lung disease as assessed by lung function (measured by forced expiratory volume at 1 second % predicted \[FEV~1~% predicted\]) and nutritional status as measured by body mass index (BMI) will be discussed.

Methods {#section2-2333794X17743424}
=======

Study Population {#section3-2333794X17743424}
----------------

CF patients aged 6 to 21 years who attended the Pediatric CF Clinic at Michigan Medicine, Mott Children's Hospital, Ann Arbor, Michigan, were included in the study. The multidisciplinary clinic manages approximately 270 pediatric CF patients. The study was conducted between June and December 2016. Eligible patients and their parents were approached to complete a questionnaire during routine clinic visit or during hospitalization.

Study Design {#section4-2333794X17743424}
------------

This is a quality improvement project. A 13-item questionnaire to assess symptoms of UI (4 questions), urgency and frequency (4 questions), FI (1 question), and bowel dysfunction (4 questions) was administered. The questionnaire took approximately 5 minutes to complete. Demographics of participants were collected including name, age, and sex. Additional information including FEV~1~% predicted and BMI percentile were documented on the day of the questionnaire completion. Sweat testing, CF mutations, history of cystic fibrosis related diabetes (CFRD), and frequency of pulmonary exacerbations (PE) requiring oral antibiotics and/or hospitalization in the past 12 months were recorded from the patients' health records. A scoring system was applied to assess the response to the questionnaire (never = 0, sometimes = 1, often = 2) with a total score range of 0 to 10 for incontinence, 0 to 8 for urgency and frequency, and 0 to 8 for bowel dysfunction. Patients with a score ≥1 were identified as having symptoms of urinary or fecal incontinence or urinary urgency and frequency or bowel dysfunction.

Data Analysis {#section5-2333794X17743424}
-------------

Data analysis was carried out using GraphPad PRISM 7.0 software. To compare variables, *t* test, χ^[@bibr2-2333794X17743424]^ test, and Pearson correlation were used. The results were noted as mean ± standard deviation and as significant when the *P* value was less than .05.

The study was approved by the University of Michigan Institution Review Board as a quality improvement project.

Results {#section6-2333794X17743424}
=======

Of a total of 186 patients in this age group, 168 patients completed the questionnaire (90.4%). The remainder were not seen during the study period or refused to participate. The baseline demographics is outlined in [Table 1](#table1-2333794X17743424){ref-type="table"}.

###### 

Baseline Demographics of the Study Population.

![](10.1177_2333794X17743424-table1)

                                                                                Total Population (N = 168)   Continent (n = 106)   Incontinent (n = 64)   Correlation Coefficient, *r* (95% CI)   *P*
  ----------------------------------------------------------------------------- ---------------------------- --------------------- ---------------------- --------------------------------------- ------
  Age (years)^[a](#table-fn2-2333794X17743424){ref-type="table-fn"}^            13.1 ± 4.4                   13.9 ± 4.3            11.9 ± 4.3                                                     .003
  Gender (female/male)                                                          84/84                        43/61                 41/23                                                          .82
  FEV~1~ (% predicted)^[a](#table-fn2-2333794X17743424){ref-type="table-fn"}^   85.3 ± 18.7                  85.3 ± 18.3           85.3 ± 18.4            0.07 (−0.17 to 0.31)                    .57
  BMI (percentile)^[a](#table-fn2-2333794X17743424){ref-type="table-fn"}^       59.1 ± 28.9                  51.6 ± 27.3           59.1 ± 28.1            −0.03 (−0.28 to 0.22)                   .79
  CF-related diabetes (n)                                                       19                           11                    8                      0.04 (−0.10 to 0.19)                    .56
  No. of PE requiring oral antibiotics in past year                             94                           55                    39                     0.062 (−0.09 to 0.21)                   .42
  No. of PE requiring IV antibiotics in past year                               56                           30                    26                     0.13 (−0.01 to 0.28)                    .07

Abbreviations: CI, confidence interval; FEV~1~, forced expiratory volume in 1 second; BMI, body mass index; CF, cystic fibrosis; PE, pulmonary exacerbation.

Data are shown as mean with standard deviation.

Sixty-four (38%) respondents reported having symptoms of PI (UI and FI). Patients with incontinence were younger than patients without, and it was more frequent in females (64%) compared with males (36%; [Table 1](#table1-2333794X17743424){ref-type="table"}). Eleven (17%) patients reported symptoms occurring as "often" and 53 (83%) reported it occurring only "sometimes."

FEV~1~% predicted and BMI percentile are listed in [Table 1](#table1-2333794X17743424){ref-type="table"} for both groups. There was a negative correlation between nutritional status and PI ([Figure 1](#fig1-2333794X17743424){ref-type="fig"}).

![Forced expiratory volume at 1 second (FEV~1~) and body mass index (BMI) comparison in patients with and without pelvic incontinence.](10.1177_2333794X17743424-fig1){#fig1-2333794X17743424}

Thirty-nine patients (41.4%) with incontinence required oral antibiotics for PE in the year prior, and 26 required hospitalizations (46.4%). There was a positive correlation between number of exacerbations requiring hospitalization and incontinence symptoms ([Table 1](#table1-2333794X17743424){ref-type="table"}).

Nineteen patients were identified with CFRD, of which 8 patients reported symptoms of PI (42%). There was no significant correlation between CFRD and PI ([Table 1](#table1-2333794X17743424){ref-type="table"}).

Of the total 64 patients, 36 (56.3%) reported symptoms of UI, 8 (12.5%) reported symptoms of FI, and 20 (31.2%) reported combined symptoms of UI and FI. The average FEV~1~ in patients with symptoms of FI was lower than those with symptoms of UI; however, the average BMI was similar in the 2 groups ([Table 2](#table2-2333794X17743424){ref-type="table"}).

###### 

Clinical Characteristics of Patients With Symptoms of Urine and Fecal Incontinence.

![](10.1177_2333794X17743424-table2)

  Characteristics                                                               Patients With Incontinence (N = 64)   *P*           
  ----------------------------------------------------------------------------- ------------------------------------- ------------- -----
  Age (years)^[a](#table-fn4-2333794X17743424){ref-type="table-fn"}^            12.4 ± 4.5                            9.7 ± 3.2     .06
  Gender (female/male)                                                          21/15                                 7/1           .08
  FEV~1~ (% predicted)^[a](#table-fn4-2333794X17743424){ref-type="table-fn"}^   88.4 ± 17.2                           81.7 ± 21.6   .37
  BMI (percentile)^[a](#table-fn4-2333794X17743424){ref-type="table-fn"}^       56.6 ± 31.5                           57.9 ± 23.9   .91

Abbreviations: FEV~1~, forced expiratory volume in 1 second; BMI, body mass index.

Data are shown as mean with standard deviation.

Of the study population, 132 (78.5%) and 123 (73%) patients reported symptoms of urgency and/or frequency and bowel dysfunction, respectively.

Discussion {#section7-2333794X17743424}
==========

The prevalence of PI was 38% among the study population. Of these, 56.3% reported symptoms of UI, 12.5% reported symptoms of FI, and 31.2% reported symptoms of combined UI and FI. This prevalence is much higher than that reported in the general pediatric population.^[@bibr16-2333794X17743424]^ A total of 482 children, aged 4 to 17 years followed at a primary care clinic during routine well-child visit, were screened for symptoms of constipation, UI, and FI. The study showed a prevalence of 10.5% for UI and 4.4% for FI.^[@bibr16-2333794X17743424]^

The prevalence of UI in our study population (56.3%) was higher than that reported in previous studies in the CF population.^[@bibr3-2333794X17743424],[@bibr5-2333794X17743424],[@bibr11-2333794X17743424],[@bibr12-2333794X17743424],[@bibr14-2333794X17743424]^ The high prevalence highlights the increased risk of having symptoms of incontinence due to frequent coughing episodes that leads to weakening of the pelvic floor muscles. FI was reported at a higher prevalence rate compared with a previous study.^[@bibr13-2333794X17743424]^ That study identified a prevalence of 8.6% among the 128 children (age 6-17 years) surveyed compared with 12.5% in our study population. The difference could be attributed to the larger population surveyed in our study, age of participants, and/or the way the questions were asked in the survey.

Similar to other studies, females reported higher prevalence of incontinence than males.^[@bibr3-2333794X17743424],[@bibr14-2333794X17743424]^ The gender difference could be because of bladder training at a young age without fully relaxing pelvic floor muscles especially in girls, which is usually carried on to adulthood.^[@bibr17-2333794X17743424]^ Reduced collagen in the pelvic floor muscles may also contribute to UI.^[@bibr18-2333794X17743424]^ A study investigating incidence of UI in nulliparous athletes found that a women's continence threshold depends on the type and frequency of stresses to which the pelvic floor muscles are exposed to, and if this threshold is exceeded, UI can occur.^[@bibr19-2333794X17743424]^ The stresses placed on the pelvic floor muscles from chronic coughing in CF patients could be large enough to exceed this continence threshold.^[@bibr14-2333794X17743424]^

Interestingly, our study did not find any correlation between severity of lung disease as measured by FEV~1~% predicted and BMI percentile and symptoms of incontinence. Two studies reported a lower FEV~1~ and BMI in their patients with incontinence.^[@bibr2-2333794X17743424],[@bibr15-2333794X17743424]^ However, in our study symptomatic patients had normal lung function, which was similar to other previously reported studies.^[@bibr5-2333794X17743424],[@bibr14-2333794X17743424],[@bibr20-2333794X17743424]^ Our study also showed a positive correlation between PE and incontinence symptoms. Therefore, a cough score could be more accurate than FEV~1~ in predicting prevalence of incontinence.^[@bibr5-2333794X17743424]^ Our study also reported a higher BMI in patients with incontinence, which is different from prior reported studies.^[@bibr2-2333794X17743424],[@bibr5-2333794X17743424],[@bibr15-2333794X17743424]^

Our study showed that patients with symptoms of FI were younger and had lower FEV~1~ than patients with symptoms of UI. These findings have not been previously studied.

Our study was limited by the subjective nature of the questionnaire. However, the main focus of the study was to identify the prevalence of these symptoms in our patients and try to correlate them with disease severity. This study is the first step in addressing these symptoms.

Symptomatic patients are currently being referred to a physiotherapist specialized in pelvic floor muscle training exercises. An algorithm is being developed for each stage of incontinence. The algorithm will specify the frequency and length of treatment according to the severity of symptoms. Patients and families have been welcoming to the intervention. Close follow-up of the intervention and patient responses will be monitored.

In conclusion, PI is more prevalent in children with CF, both males and females, compared with the general population. Since patients with incontinence in our study had normal lung function and BMI, screening for these symptoms is crucial in all CF patients regardless of disease severity. It can prevent long-term consequences on their overall health and improve quality of life.
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